|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225 USD | +1.55% |
|
-1.76% | -13.04% |
| 07-16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
| 07-16 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
Jan 5 (Reuters) - Biogen Inc on Thursday named Interim Research and Development Chief Priya Singhal as executive vice president, head of development following the separation of the drugmaker's R&D division into two units. (Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.04% | 32.26B | |
| +7.75% | 101B | |
| +8.42% | 42.18B | |
| +80.80% | 29.79B | |
| -10.92% | 16.06B | |
| +1.93% | 14.45B | |
| -6.77% | 12.01B | |
| +177.16% | 10.71B | |
| +4.12% | 8.89B | |
| -56.13% | 8.83B |
BIOGEN INC. 
